rs35887544
Positions:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_021008.4(DEAF1):āc.882C>Gā(p.Val294=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00974 in 1,614,090 control chromosomes in the GnomAD database, including 100 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.0075 ( 3 hom., cov: 32)
Exomes š: 0.010 ( 97 hom. )
Consequence
DEAF1
NM_021008.4 synonymous
NM_021008.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.442
Genes affected
DEAF1 (HGNC:14677): (DEAF1 transcription factor) This gene encodes a zinc finger domain-containing protein that functions as a regulator of transcription. The encoded proteins binds to its own promoter as well as to that of several target genes. Activity of this protein is important in the regulation of embryonic development. Mutations in this gene have been found in individuals with autosomal dominant cognitive disability. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jun 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.48).
BP6
Variant 11-681078-G-C is Benign according to our data. Variant chr11-681078-G-C is described in ClinVar as [Benign]. Clinvar id is 585777.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.442 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00748 (1139/152276) while in subpopulation NFE AF= 0.0112 (764/68022). AF 95% confidence interval is 0.0106. There are 3 homozygotes in gnomad4. There are 501 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 3 SD gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DEAF1 | NM_021008.4 | c.882C>G | p.Val294= | synonymous_variant | 7/12 | ENST00000382409.4 | NP_066288.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DEAF1 | ENST00000382409.4 | c.882C>G | p.Val294= | synonymous_variant | 7/12 | 1 | NM_021008.4 | ENSP00000371846 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00748 AC: 1138AN: 152158Hom.: 3 Cov.: 32
GnomAD3 genomes
AF:
AC:
1138
AN:
152158
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00843 AC: 2119AN: 251480Hom.: 22 AF XY: 0.00853 AC XY: 1160AN XY: 135918
GnomAD3 exomes
AF:
AC:
2119
AN:
251480
Hom.:
AF XY:
AC XY:
1160
AN XY:
135918
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00997 AC: 14578AN: 1461814Hom.: 97 Cov.: 32 AF XY: 0.0100 AC XY: 7274AN XY: 727206
GnomAD4 exome
AF:
AC:
14578
AN:
1461814
Hom.:
Cov.:
32
AF XY:
AC XY:
7274
AN XY:
727206
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00748 AC: 1139AN: 152276Hom.: 3 Cov.: 32 AF XY: 0.00673 AC XY: 501AN XY: 74454
GnomAD4 genome
AF:
AC:
1139
AN:
152276
Hom.:
Cov.:
32
AF XY:
AC XY:
501
AN XY:
74454
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
3
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:4
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jul 01, 2024 | DEAF1: BP4, BP7, BS1, BS2 - |
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Oct 25, 2017 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at